Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment

S M Habib, M G H Betjes*, Eps Registry, M W J A Fieren, E W Boeschoten, A C Abrahams, W H Boer, D G Struijk, W Ruger, C Krikke, R Westerhuis, R G L de Sévaux, F M van der Sande, A Gaasbeek, M R Korte

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

72 Citations (Scopus)
14 Downloads (Pure)

Abstract

Encapsulating peritoneal sclerosis (EPS) represents a rare complication of long-term peritoneal dialysis (PD). It is characterised by diffuse peritoneal membrane fibrosis, progressive intestinal encapsulation and the clinical spectrum of intestinal obstruction. The pathogenesis is as yet not well understood but includes inflammation, angiogenesis and fibrosis. The current diagnosis of EPS lacks specificity and relies on clinical, radiographic or macroscopic evaluation. There is no general agreement on managing EPS although accumulating clinical data suggest drug treatment (steroids, tamoxifen), surgery (enterolysis) or a combination of both. Here, we provide a short overview on the current knowledge of EPS, with a focus on treatment. Moreover, we present a diagnostic and a therapeutic algorithm for EPS based on the best available published data and our combined experience.

Original languageEnglish
Pages (from-to)500-7
Number of pages8
JournalNetherlands Journal of Medicine
Volume69
Issue number11
Publication statusPublished - Dec 2011

Fingerprint

Dive into the research topics of 'Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment'. Together they form a unique fingerprint.

Cite this